(Note: Thank you for supporting businesses like the one presenting a sponsored message below and working with them through the links below which benefits Gateway Pundit. We appreciate your support!)
Thanks to the failed COVID-19 approaches, COVID will likely be a part of our lives for the foreseeable futures. Indeed, instead of a once-a-year surge in COVID cases, new strains are leading to a twice a year surge in COVID – and according to the CDC we are looking at a summer surge:
The summer surge of COVID-19 is here, with data from the Centers for Disease Control and Prevention showing increases across much of the country.
In its latest report, the CDC said the number of cases is now growing or likely growing in at least 26 states and Washington, D.C. COVID-related emergency room visits for young kids are also the highest they’ve been since March, according to the data.
The good news is that we no longer have to rely on the failed approaches of the past. Forget vaccines and boosters and masks and social distancing, we now know there are a variety of safe and effective treatments.
One promising treatment, which has been in the news for other uses, is methylene blue. According to Dr. Peter McCullough:
A review by Emadi et al of 34 studies, in general, found favorable effects with topical (with photodynamic therapy), oral, and intravenous methylene blue.
Based on studies, MB can simultaneously affect most of the host’s harmful responses caused by SARS-CoV-2 infection due to its multiple properties, including anti-hypoxemia, anti-oxidant, immune system modulator, and antiviral. The use of MB is associated with a reduction in the possibility of getting infection, and mortality, and can be used as a safe, effective, cheap, and available treatment option with minimal side effects for the clinical management of COVID-19.
Earlier this year, methylene blue hit the mainstream after it was discovered MAHA celebrities like Mel Gibson, Joe Rogan, and even RFK Jr himself, take methylene blue!
Few men have defied the effects of Father Time better than the trio of Joe Rogan, Mel Gibson and RFK Jr, so it wasn’t not surprising that everyone is looking for more information on Methylene blue. While Methylene blue is just now going mainstream, it isn’t new to many in the know, according to The New York Post:
In recent years, celebrities, wellness influencers and biohackers have touted methylene blue for several off-label uses, claiming it can boost energy levels and metabolism, enhance cognitive function and combat aging — though evidence remains limited.
Early research suggests that methylene blue may have antioxidant properties that help reduce toxic proteins in the brain, potentially aiding in the prevention of neurodegenerative diseases like Alzheimer’s and Parkinson’s.
Some studies also indicate that the drug may help delay skin aging by stimulating the production of collagen and elastin, reducing cellular damage and promoting wound healing.
WHAT IS METHYLENE BLUE?
First used in the 1800s, today, this century-old compound is FDA-approved for methemoglobinemia (a condition in which the blood can’t carry oxygen properly) but has garnered renewed interest for its off-label applications, particularly in enhancing mitochondrial function, combating neurodegenerative diseases, and as adjunct treatment of long COVID.
How methylene blue works and its “off-label” uses:
Energy Backup: Methylene blue acts like a “backup generator” for your cells’ energy factories (mitochondria). When part of the energy production line (specifically “Complex I”) breaks down—due to toxins, disease, or aging—methylene blue moves electrons directly to later stages of the energy-making process, allowing cells to keep producing energy (ATP) even when parts of the system are damaged.
Oxidative Stress Reduction: It acts like a molecular sponge, soaking up harmful molecules called reactive oxygen species (ROS) that damage cells. By neutralizing these destructive molecules, it reduces oxidative stress—a key contributor to aging and diseases like Alzheimer’s. It also blocks caspase-6, an enzyme that drives brain inflammation and kills neurons in Alzheimer’s patients. Think of it as a two-in-one protector: it calms oxidative damage while stopping the enzyme that fuels brain cell death.
HOW YOU CAN GET METHYLENE BLUE
The medical experts at The Wellness Company – like Dr. Peter McCullough and Dr. Kelly Victory – were leaders in the efforts to provide the public with accurate medical information during COVID. These experts have repeatedly shown that they prioritized the health and welfare of their patients over the bottom line of the big pharmaceutical companies.
Now the experts at The Wellness Company are making methylene blue available to you at home with RECHARGE!
RECHARGE your cells with the first-ever combination of Methylene Blue and Urolithin A. Experience enhanced cognitive function and ultimate mitochondrial health.
From sharper thinking to stronger cells, Methylene Blue enhances how your brain and body perform by enhancing mental clarity and focus, supporting blood flow, and increasing ATP production.
Urolithin A promotes healthy aging by activating mitophagy. Mitophagy helps the body to recycle and rebuild mitochondria (the powerhouses of your cells) and enhances the benefits of Methylene Blue.
RECHARGE has been scientifically formulated with research-backed ingredients to enhance mental clarity and focus and support ultimate mitochondrial health. Methylene Blue and Urolithin A are a powerful combo with potent antioxidants for healthy, youthful cells.
Whether it’s fighting off COVID or Father Time, see if methylene blue is for you – order RECHARGE now.
Note: The information provided on this website is intended for informational purposes only and should not be considered medical advice or used as a substitute for professional healthcare guidance. It is your responsibility to comply with all applicable laws, regulations, and guidelines regarding the purchase, possession, and use of prescription medications.
The post Dr. Peter McCullough On Another Promising Use For Methylene Blue appeared first on The Gateway Pundit.